Shilpa Medicare Ltd

SHILPAMED

Company Profile

  • Business description

    Shilpa Medicare Ltd is a specialty and generic drug manufacturer. The company deals in high-quality Active Pharmaceutical Ingredients (APIs), Intermediates, Formulations, New Drug Delivery Systems, Peptides, Biotech products, and Specialty Chemicals etc. Its portfolio comprises various oncology and non-oncology-related APIs such as anastrozole, acebrophylline, busulphan, decitabine, etc, and finished dosage formulations such as apremilast tablets, clofarabine injection, docetaxel injection, etc., in various therapy areas. Its reporting segments are: Pharmaceutical product and services, which derive maximum revenue, Power sales, and Others. Geographically, the company generates maximum revenue from India, followed by Europe, the United States of America, and the Rest of the world.

  • Contact

    Hyderabad Road
    No. 12-6-214/A-1, Shilpa House
    RaichurKA584135
    IND

    T: +91 8532238704

    https://www.vbshilpa.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2026

    Employees

    998

Stocks News & Analysis

stocks

2 ASX shares that benefit from sticky inflation

Inflation is a key risk to shareholders. Here’s why these two ASX shares benefit from higher inflation.
stocks

Our view of Dexus / Scentre deal

Dexus acquires stake in Westfiend Chermside.
stocks

Undervalued ASX retailer benefiting from rebound in spending

Uplift in sales momentum continues.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,874.2025.800.29%
CAC 408,111.865.700.07%
DAX 4024,123.7946.920.19%
Dow JONES (US)48,114.26302.30-0.62%
FTSE 1009,829.15144.361.49%
HKSE25,468.78233.370.92%
NASDAQ23,111.4654.050.23%
Nikkei 22549,512.28128.990.26%
NZX 50 Index13,295.91129.04-0.96%
S&P 5006,800.2616.25-0.24%
S&P/ASX 2008,585.2021.600.25%
SSE Composite Index3,870.2845.471.19%

Market Movers